Complexities in estimating the true risk of hereditary leiomyomatosis and renal cell carcinoma and the development of kidney cancer
Currently, the incidence of hereditary leiomyomatosis and renal cell cancer (HLRCC), as well as the penetrance of kidney cancer among patients with HLRCC, is unknown. Large‐scale genomic databases may be unable to accurately estimate the incidence of HLRCC.
Gespeichert in:
| Veröffentlicht in: | Cancer 2020-08, Vol.126 (16), p.3617-3619 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3619 |
|---|---|
| container_issue | 16 |
| container_start_page | 3617 |
| container_title | Cancer |
| container_volume | 126 |
| creator | Ball, Mark W. Ricketts, Christopher J. |
| description | Currently, the incidence of hereditary leiomyomatosis and renal cell cancer (HLRCC), as well as the penetrance of kidney cancer among patients with HLRCC, is unknown. Large‐scale genomic databases may be unable to accurately estimate the incidence of HLRCC. |
| doi_str_mv | 10.1002/cncr.32915 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8557352</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2404045849</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4485-4856eee2476fe33cae5227c483a5f5e03848e5dad31ac425a99447ef1cfa62613</originalsourceid><addsrcrecordid>eNp9kVtrFTEUhYNY7LH64g-QgC8iTM11Li9CGbxBaUEUfAsxs6cn7UxyTGaq8-wfd09PW9QHCckm7I_F2nsR8oyzY86YeO2CS8dSNFw_IBvOmqpgXImHZMMYqwut5NdD8jjnS_xWQstH5FAKxSUv2Yb8auO4G-Cnnzxk6gOFPPnRTj5c0GkLdEoz0OTzFY093UKCzk82LXQAH8clIhmzz9SGjiYIdqAOBnxscj5g96ax6nRwDUPcjRCmVenKdwEW5IKD9IQc9HbI8PS2HpEv795-bj8Up-fvP7Ynp4VTqtYF3hIAhKrKHqR0FrQQlVO1tLrXwGStatCd7SS3Tgltm0apCnrueluKkssj8mavu5u_jdA59JLsYHYJB06LidabvzvBb81FvDa11pXUAgVe3gqk-H3GTZnR53VgGyDO2QjF8OhaNYi--Ae9jHPCBa0UmtFlLRlSr_aUSzHnBP29Gc7Mmq1ZszU32SL8_E_79-hdmAjwPfDDD7D8R8q0Z-2nvehv9rOyCg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2426156830</pqid></control><display><type>article</type><title>Complexities in estimating the true risk of hereditary leiomyomatosis and renal cell carcinoma and the development of kidney cancer</title><source>Wiley Free Content</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library All Journals</source><source>Alma/SFX Local Collection</source><creator>Ball, Mark W. ; Ricketts, Christopher J.</creator><creatorcontrib>Ball, Mark W. ; Ricketts, Christopher J.</creatorcontrib><description>Currently, the incidence of hereditary leiomyomatosis and renal cell cancer (HLRCC), as well as the penetrance of kidney cancer among patients with HLRCC, is unknown. Large‐scale genomic databases may be unable to accurately estimate the incidence of HLRCC.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.32915</identifier><identifier>PMID: 32413160</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Cancer ; cancer genetics ; Fibroids ; hereditary ; hereditary leiomyomatosis and renal cell cancer ; HLRCC ; Kidney cancer ; Kidneys ; Renal cell carcinoma</subject><ispartof>Cancer, 2020-08, Vol.126 (16), p.3617-3619</ispartof><rights>2020 American Cancer Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4485-4856eee2476fe33cae5227c483a5f5e03848e5dad31ac425a99447ef1cfa62613</citedby><cites>FETCH-LOGICAL-c4485-4856eee2476fe33cae5227c483a5f5e03848e5dad31ac425a99447ef1cfa62613</cites><orcidid>0000-0003-1780-2627</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fcncr.32915$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fcncr.32915$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1416,1432,27922,27923,45572,45573,46407,46831</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32413160$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ball, Mark W.</creatorcontrib><creatorcontrib>Ricketts, Christopher J.</creatorcontrib><title>Complexities in estimating the true risk of hereditary leiomyomatosis and renal cell carcinoma and the development of kidney cancer</title><title>Cancer</title><addtitle>Cancer</addtitle><description>Currently, the incidence of hereditary leiomyomatosis and renal cell cancer (HLRCC), as well as the penetrance of kidney cancer among patients with HLRCC, is unknown. Large‐scale genomic databases may be unable to accurately estimate the incidence of HLRCC.</description><subject>Cancer</subject><subject>cancer genetics</subject><subject>Fibroids</subject><subject>hereditary</subject><subject>hereditary leiomyomatosis and renal cell cancer</subject><subject>HLRCC</subject><subject>Kidney cancer</subject><subject>Kidneys</subject><subject>Renal cell carcinoma</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kVtrFTEUhYNY7LH64g-QgC8iTM11Li9CGbxBaUEUfAsxs6cn7UxyTGaq8-wfd09PW9QHCckm7I_F2nsR8oyzY86YeO2CS8dSNFw_IBvOmqpgXImHZMMYqwut5NdD8jjnS_xWQstH5FAKxSUv2Yb8auO4G-Cnnzxk6gOFPPnRTj5c0GkLdEoz0OTzFY093UKCzk82LXQAH8clIhmzz9SGjiYIdqAOBnxscj5g96ax6nRwDUPcjRCmVenKdwEW5IKD9IQc9HbI8PS2HpEv795-bj8Up-fvP7Ynp4VTqtYF3hIAhKrKHqR0FrQQlVO1tLrXwGStatCd7SS3Tgltm0apCnrueluKkssj8mavu5u_jdA59JLsYHYJB06LidabvzvBb81FvDa11pXUAgVe3gqk-H3GTZnR53VgGyDO2QjF8OhaNYi--Ae9jHPCBa0UmtFlLRlSr_aUSzHnBP29Gc7Mmq1ZszU32SL8_E_79-hdmAjwPfDDD7D8R8q0Z-2nvehv9rOyCg</recordid><startdate>20200815</startdate><enddate>20200815</enddate><creator>Ball, Mark W.</creator><creator>Ricketts, Christopher J.</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1780-2627</orcidid></search><sort><creationdate>20200815</creationdate><title>Complexities in estimating the true risk of hereditary leiomyomatosis and renal cell carcinoma and the development of kidney cancer</title><author>Ball, Mark W. ; Ricketts, Christopher J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4485-4856eee2476fe33cae5227c483a5f5e03848e5dad31ac425a99447ef1cfa62613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Cancer</topic><topic>cancer genetics</topic><topic>Fibroids</topic><topic>hereditary</topic><topic>hereditary leiomyomatosis and renal cell cancer</topic><topic>HLRCC</topic><topic>Kidney cancer</topic><topic>Kidneys</topic><topic>Renal cell carcinoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ball, Mark W.</creatorcontrib><creatorcontrib>Ricketts, Christopher J.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ball, Mark W.</au><au>Ricketts, Christopher J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Complexities in estimating the true risk of hereditary leiomyomatosis and renal cell carcinoma and the development of kidney cancer</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>2020-08-15</date><risdate>2020</risdate><volume>126</volume><issue>16</issue><spage>3617</spage><epage>3619</epage><pages>3617-3619</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>Currently, the incidence of hereditary leiomyomatosis and renal cell cancer (HLRCC), as well as the penetrance of kidney cancer among patients with HLRCC, is unknown. Large‐scale genomic databases may be unable to accurately estimate the incidence of HLRCC.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>32413160</pmid><doi>10.1002/cncr.32915</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0003-1780-2627</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0008-543X |
| ispartof | Cancer, 2020-08, Vol.126 (16), p.3617-3619 |
| issn | 0008-543X 1097-0142 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8557352 |
| source | Wiley Free Content; EZB-FREE-00999 freely available EZB journals; Wiley Online Library All Journals; Alma/SFX Local Collection |
| subjects | Cancer cancer genetics Fibroids hereditary hereditary leiomyomatosis and renal cell cancer HLRCC Kidney cancer Kidneys Renal cell carcinoma |
| title | Complexities in estimating the true risk of hereditary leiomyomatosis and renal cell carcinoma and the development of kidney cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T22%3A35%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Complexities%20in%20estimating%20the%20true%20risk%20of%20hereditary%20leiomyomatosis%20and%20renal%20cell%20carcinoma%20and%20the%20development%20of%20kidney%20cancer&rft.jtitle=Cancer&rft.au=Ball,%20Mark%20W.&rft.date=2020-08-15&rft.volume=126&rft.issue=16&rft.spage=3617&rft.epage=3619&rft.pages=3617-3619&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/cncr.32915&rft_dat=%3Cproquest_pubme%3E2404045849%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2426156830&rft_id=info:pmid/32413160&rfr_iscdi=true |